APO Research

APO RESEARCH · REPORT

Tiapride Hydrochloride Tablets

Selected research

Market Structure

Global Tiapride Hydrochloride Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Tiapride Hydrochloride Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Tiapride Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tiapride Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tiapride Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Tiapride Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tiapride Hydrochloride Tablets include Jiangsu Nhwa Pharmaceutical, Tianjin Pharmaceutical Da Ren Tang Group, Astellas Pharma, Tasly Pharmaceuticals, Sawai Pharmaceutical, Nihon Generic and Grand Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Tiapride Hydrochloride Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tiapride Hydrochloride Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tiapride Hydrochloride Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tiapride Hydrochloride Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Tiapride Hydrochloride Tablets Segment by Company

Jiangsu Nhwa Pharmaceutical

Tianjin Pharmaceutical Da Ren Tang Group

Astellas Pharma

Tasly Pharmaceuticals

Sawai Pharmaceutical

Nihon Generic

Grand Pharmaceutical

Tiapride Hydrochloride Tablets Segment by Type

100mg

50mg

Tiapride Hydrochloride Tablets Segment by Application

Hospital

Clinic

Others

Tiapride Hydrochloride Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tiapride Hydrochloride Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tiapride Hydrochloride Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tiapride Hydrochloride Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Tiapride Hydrochloride Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tiapride Hydrochloride Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Tiapride Hydrochloride Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Tiapride Hydrochloride Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Tiapride Hydrochloride Tablets Industry Trends Table 2. Tiapride Hydrochloride Tablets Industry Drivers Table 3. Tiapride Hydrochloride Tablets Industry Opportunities and Challenges Table 4. Tiapride Hydrochloride Tablets Industry Restraints Table 5. Global Tiapride Hydrochloride Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Tiapride Hydrochloride Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Tiapride Hydrochloride Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Tiapride Hydrochloride Tablets Sales Market Share by Manufacturers Table 9. Global Tiapride Hydrochloride Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Tiapride Hydrochloride Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Tiapride Hydrochloride Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Tiapride Hydrochloride Tablets Manufacturers, Product Type & Application Table 13. Global Tiapride Hydrochloride Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Tiapride Hydrochloride Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 100mg Table 17. Major Manufacturers of 50mg Table 18. Global Tiapride Hydrochloride Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Tiapride Hydrochloride Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Tiapride Hydrochloride Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Tiapride Hydrochloride Tablets Sales Market Share by Type (2021-2026) Table 22. Global Tiapride Hydrochloride Tablets Sales Market Share by Type (2027-2032) Table 23. Global Tiapride Hydrochloride Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Tiapride Hydrochloride Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Tiapride Hydrochloride Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Tiapride Hydrochloride Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Tiapride Hydrochloride Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Others Table 31. Global Tiapride Hydrochloride Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Tiapride Hydrochloride Tablets Sales by Application (2021-2026) & (K Units) Table 33. Global Tiapride Hydrochloride Tablets Sales by Application (2027-2032) & (K Units) Table 34. Global Tiapride Hydrochloride Tablets Sales Market Share by Application (2021-2026) Table 35. Global Tiapride Hydrochloride Tablets Sales Market Share by Application (2027-2032) Table 36. Global Tiapride Hydrochloride Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Tiapride Hydrochloride Tablets Revenue by Application (2021-2026) & (K Units) Table 38. Global Tiapride Hydrochloride Tablets Revenue by Application (2027-2032) & (K Units) Table 39. Global Tiapride Hydrochloride Tablets Revenue Market Share by Application (2021-2026) Table 40. Global Tiapride Hydrochloride Tablets Revenue Market Share by Application (2027-2032) Table 41. Global Tiapride Hydrochloride Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Tiapride Hydrochloride Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Tiapride Hydrochloride Tablets Sales Market Share by Region (2021-2026) Table 44. Global Tiapride Hydrochloride Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Tiapride Hydrochloride Tablets Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Tiapride Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Tiapride Hydrochloride Tablets Sales by Country (2021-2026) & (K Units) Table 48. North America Tiapride Hydrochloride Tablets Sales by Country (2027-2032) & (K Units) Table 49. Europe Tiapride Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Tiapride Hydrochloride Tablets Sales by Country (2021-2026) & (K Units) Table 51. Europe Tiapride Hydrochloride Tablets Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Tiapride Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Tiapride Hydrochloride Tablets Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Tiapride Hydrochloride Tablets Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Tiapride Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Tiapride Hydrochloride Tablets Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Tiapride Hydrochloride Tablets Sales by Country (2027-2032) & (K Units) Table 58. Global Tiapride Hydrochloride Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Tiapride Hydrochloride Tablets Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Tiapride Hydrochloride Tablets Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Tiapride Hydrochloride Tablets Revenue Market Share by Region (2021-2026) Table 62. Global Tiapride Hydrochloride Tablets Revenue Market Share by Region (2027-2032) Table 63. Jiangsu Nhwa Pharmaceutical Company Information Table 64. Jiangsu Nhwa Pharmaceutical Business Overview Table 65. Jiangsu Nhwa Pharmaceutical Tiapride Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Jiangsu Nhwa Pharmaceutical Tiapride Hydrochloride Tablets Product Portfolio Table 67. Jiangsu Nhwa Pharmaceutical Recent Development Table 68. Tianjin Pharmaceutical Da Ren Tang Group Company Information Table 69. Tianjin Pharmaceutical Da Ren Tang Group Business Overview Table 70. Tianjin Pharmaceutical Da Ren Tang Group Tiapride Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Tianjin Pharmaceutical Da Ren Tang Group Tiapride Hydrochloride Tablets Product Portfolio Table 72. Tianjin Pharmaceutical Da Ren Tang Group Recent Development Table 73. Astellas Pharma Company Information Table 74. Astellas Pharma Business Overview Table 75. Astellas Pharma Tiapride Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Astellas Pharma Tiapride Hydrochloride Tablets Product Portfolio Table 77. Astellas Pharma Recent Development Table 78. Tasly Pharmaceuticals Company Information Table 79. Tasly Pharmaceuticals Business Overview Table 80. Tasly Pharmaceuticals Tiapride Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Tasly Pharmaceuticals Tiapride Hydrochloride Tablets Product Portfolio Table 82. Tasly Pharmaceuticals Recent Development Table 83. Sawai Pharmaceutical Company Information Table 84. Sawai Pharmaceutical Business Overview Table 85. Sawai Pharmaceutical Tiapride Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Sawai Pharmaceutical Tiapride Hydrochloride Tablets Product Portfolio Table 87. Sawai Pharmaceutical Recent Development Table 88. Nihon Generic Company Information Table 89. Nihon Generic Business Overview Table 90. Nihon Generic Tiapride Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Nihon Generic Tiapride Hydrochloride Tablets Product Portfolio Table 92. Nihon Generic Recent Development Table 93. Grand Pharmaceutical Company Information Table 94. Grand Pharmaceutical Business Overview Table 95. Grand Pharmaceutical Tiapride Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Grand Pharmaceutical Tiapride Hydrochloride Tablets Product Portfolio Table 97. Grand Pharmaceutical Recent Development Table 98. Key Raw Materials Table 99. Raw Materials Key Suppliers Table 100. Tiapride Hydrochloride Tablets Distributors List Table 101. Tiapride Hydrochloride Tablets Customers List Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Tiapride Hydrochloride Tablets Product Image Figure 2. Global Tiapride Hydrochloride Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tiapride Hydrochloride Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Tiapride Hydrochloride Tablets Sales (2021-2032) & (K Units) Figure 5. Global Tiapride Hydrochloride Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Tiapride Hydrochloride Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 100mg Image Figure 9. 50mg Image Figure 10. Global Tiapride Hydrochloride Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Tiapride Hydrochloride Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Tiapride Hydrochloride Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Tiapride Hydrochloride Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Tiapride Hydrochloride Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Tiapride Hydrochloride Tablets Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Others Image Figure 19. Global Tiapride Hydrochloride Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Tiapride Hydrochloride Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Tiapride Hydrochloride Tablets Sales Market Share by Application (2021-2032) Figure 22. Global Tiapride Hydrochloride Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Tiapride Hydrochloride Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Tiapride Hydrochloride Tablets Revenue Market Share by Application (2021-2032) Figure 25. North America Tiapride Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Tiapride Hydrochloride Tablets Sales Market Share by Country (2021-2032) Figure 27. U.S. Tiapride Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Tiapride Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Tiapride Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Tiapride Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Tiapride Hydrochloride Tablets Sales Market Share by Country (2021-2032) Figure 32. Germany Tiapride Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Tiapride Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Tiapride Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Tiapride Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Tiapride Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Tiapride Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Tiapride Hydrochloride Tablets Sales Market Share by Country (2021-2032) Figure 39. China Tiapride Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Tiapride Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Tiapride Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Tiapride Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Tiapride Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Tiapride Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Tiapride Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Tiapride Hydrochloride Tablets Sales Market Share by Country (2021-2032) Figure 47. Brazil Tiapride Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Tiapride Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Tiapride Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Tiapride Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Tiapride Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Tiapride Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Tiapride Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Tiapride Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Tiapride Hydrochloride Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Tiapride Hydrochloride Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Tiapride Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Figure 58. North America Tiapride Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Tiapride Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Figure 60. Europe Tiapride Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Tiapride Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Tiapride Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Tiapride Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Tiapride Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Tiapride Hydrochloride Tablets Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Tiapride Hydrochloride Tablets Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg
  • 50mg
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Jiangsu Nhwa Pharmaceutical
  • Tianjin Pharmaceutical Da Ren Tang Group
  • Astellas Pharma
  • Tasly Pharmaceuticals
  • Sawai Pharmaceutical
  • Nihon Generic
  • Grand Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Tiapride Hydrochloride Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Tiapride Hydrochloride Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Tiapride Hydrochloride Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Tiapride Hydrochloride Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Tiapride Hydrochloride Tablets Market Dynamics
  1. 2.1 Tiapride Hydrochloride Tablets Industry Trends
  2. 2.2 Tiapride Hydrochloride Tablets Industry Drivers
  3. 2.3 Tiapride Hydrochloride Tablets Industry Opportunities and Challenges
  4. 2.4 Tiapride Hydrochloride Tablets Industry Restraints
3 Tiapride Hydrochloride Tablets Market by Manufacturers
  1. 3.1 Global Tiapride Hydrochloride Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Tiapride Hydrochloride Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Tiapride Hydrochloride Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Tiapride Hydrochloride Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tiapride Hydrochloride Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Tiapride Hydrochloride Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Tiapride Hydrochloride Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tiapride Hydrochloride Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tiapride Hydrochloride Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tiapride Hydrochloride Tablets Tier 1, Tier 2, and Tier 3
4 Tiapride Hydrochloride Tablets Market by Type
  1. 4.1 Tiapride Hydrochloride Tablets Type Introduction
  2. 4.1.1 100mg
  3. 4.1.2 50mg
  4. 4.2 Global Tiapride Hydrochloride Tablets Sales by Type
  5. 4.2.1 Global Tiapride Hydrochloride Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Tiapride Hydrochloride Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Tiapride Hydrochloride Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Tiapride Hydrochloride Tablets Revenue by Type
  9. 4.3.1 Global Tiapride Hydrochloride Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Tiapride Hydrochloride Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Tiapride Hydrochloride Tablets Revenue Market Share by Type (2021-2032)
5 Tiapride Hydrochloride Tablets Market by Application
  1. 5.1 Tiapride Hydrochloride Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Tiapride Hydrochloride Tablets Sales by Application
  6. 5.2.1 Global Tiapride Hydrochloride Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Tiapride Hydrochloride Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Tiapride Hydrochloride Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Tiapride Hydrochloride Tablets Revenue by Application
  10. 5.3.1 Global Tiapride Hydrochloride Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Tiapride Hydrochloride Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Tiapride Hydrochloride Tablets Revenue Market Share by Application (2021-2032)
6 Global Tiapride Hydrochloride Tablets Sales by Region
  1. 6.1 Global Tiapride Hydrochloride Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tiapride Hydrochloride Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Tiapride Hydrochloride Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Tiapride Hydrochloride Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Tiapride Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Tiapride Hydrochloride Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Tiapride Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Tiapride Hydrochloride Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Tiapride Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Tiapride Hydrochloride Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Tiapride Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Tiapride Hydrochloride Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Tiapride Hydrochloride Tablets Revenue by Region
  1. 7.1 Global Tiapride Hydrochloride Tablets Revenue by Region
  2. 7.1.1 Global Tiapride Hydrochloride Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Tiapride Hydrochloride Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Tiapride Hydrochloride Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Tiapride Hydrochloride Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Tiapride Hydrochloride Tablets Revenue (2021-2032)
  8. 7.2.2 North America Tiapride Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Tiapride Hydrochloride Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Tiapride Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Tiapride Hydrochloride Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Tiapride Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Tiapride Hydrochloride Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Tiapride Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Jiangsu Nhwa Pharmaceutical
  2. 8.1.1 Jiangsu Nhwa Pharmaceutical Company Information
  3. 8.1.2 Jiangsu Nhwa Pharmaceutical Business Overview
  4. 8.1.3 Jiangsu Nhwa Pharmaceutical Tiapride Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Jiangsu Nhwa Pharmaceutical Tiapride Hydrochloride Tablets Product Portfolio
  6. 8.1.5 Jiangsu Nhwa Pharmaceutical Recent Developments
  7. 8.2 Tianjin Pharmaceutical Da Ren Tang Group
  8. 8.2.1 Tianjin Pharmaceutical Da Ren Tang Group Company Information
  9. 8.2.2 Tianjin Pharmaceutical Da Ren Tang Group Business Overview
  10. 8.2.3 Tianjin Pharmaceutical Da Ren Tang Group Tiapride Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Tianjin Pharmaceutical Da Ren Tang Group Tiapride Hydrochloride Tablets Product Portfolio
  12. 8.2.5 Tianjin Pharmaceutical Da Ren Tang Group Recent Developments
  13. 8.3 Astellas Pharma
  14. 8.3.1 Astellas Pharma Company Information
  15. 8.3.2 Astellas Pharma Business Overview
  16. 8.3.3 Astellas Pharma Tiapride Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Astellas Pharma Tiapride Hydrochloride Tablets Product Portfolio
  18. 8.3.5 Astellas Pharma Recent Developments
  19. 8.4 Tasly Pharmaceuticals
  20. 8.4.1 Tasly Pharmaceuticals Company Information
  21. 8.4.2 Tasly Pharmaceuticals Business Overview
  22. 8.4.3 Tasly Pharmaceuticals Tiapride Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Tasly Pharmaceuticals Tiapride Hydrochloride Tablets Product Portfolio
  24. 8.4.5 Tasly Pharmaceuticals Recent Developments
  25. 8.5 Sawai Pharmaceutical
  26. 8.5.1 Sawai Pharmaceutical Company Information
  27. 8.5.2 Sawai Pharmaceutical Business Overview
  28. 8.5.3 Sawai Pharmaceutical Tiapride Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sawai Pharmaceutical Tiapride Hydrochloride Tablets Product Portfolio
  30. 8.5.5 Sawai Pharmaceutical Recent Developments
  31. 8.6 Nihon Generic
  32. 8.6.1 Nihon Generic Company Information
  33. 8.6.2 Nihon Generic Business Overview
  34. 8.6.3 Nihon Generic Tiapride Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Nihon Generic Tiapride Hydrochloride Tablets Product Portfolio
  36. 8.6.5 Nihon Generic Recent Developments
  37. 8.7 Grand Pharmaceutical
  38. 8.7.1 Grand Pharmaceutical Company Information
  39. 8.7.2 Grand Pharmaceutical Business Overview
  40. 8.7.3 Grand Pharmaceutical Tiapride Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Grand Pharmaceutical Tiapride Hydrochloride Tablets Product Portfolio
  42. 8.7.5 Grand Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Tiapride Hydrochloride Tablets Value Chain Analysis
  2. 9.1.1 Tiapride Hydrochloride Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Tiapride Hydrochloride Tablets Production Mode & Process
  6. 9.2 Tiapride Hydrochloride Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Tiapride Hydrochloride Tablets Distributors
  9. 9.2.3 Tiapride Hydrochloride Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research